查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2100073

吸入麻醉劑市場－2026-2032年全球市場預測

Inhalation Anesthetics Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，吸入麻醉劑市場規模將達到 20 億美元，複合年成長率為 6.85%。

主要市場統計數據
基準年 2025 12.5億美元
預計年份：2026年 13.4億美元
預測年份：2032年 20億美元
複合年成長率 (%) 6.85%

吸入麻醉劑仍然是現代麻醉的基石，能夠在各種外科手術和操作環境中實現可控的誘導、維持和恢復。SEVOFLURANE、DESFLURANE、Isoflurane和氧化亞氮等藥物廣泛應用於手術室、門診手術中心、產科病房以及某些重症監護室，在這些場所，快速調整劑量和可預測的恢復至關重要。需求成長受到手術量增加、人口老化導致手術需求上升、門診手術的擴展以及對手術全期安全的持續投入等因素的影響。同時，吸入麻醉劑市場也日益受到環境監測的加強、職業暴露管理、低流量麻醉技術以及支持精確給藥和氣體監測的先進麻醉工作站的引入的影響。對於醫療保健專業人員、採購團隊和相關人員，該市場不僅取決於臨床療效，還取決於永續性、供應可靠性、法規遵循和整體醫療保健成本。

吸入麻醉劑領域的變革性變化

在吸入麻醉劑領域，麻醉管理模式正經歷著從傳統產品使用轉向以價值為主導、注重安全性和環保的轉變。醫院正在採用低流量和最小流量麻醉方案，以在保持適當麻醉深度和病人安全的同時，降低麻醉氣體的消耗量。現代化的麻醉蒸發器、整合氣體分析儀、封閉回路型監測概念以及專注於最佳化新鮮氣體流量的臨床培訓，都為這一轉變提供了支持。此外，由於揮發性麻醉劑的停留時間和全球暖化潛勢值各不相同，環境因素正在重塑藥物選擇決策，導致許多醫療系統加強了對DESFLURANE和氧化亞氮的監測。同時，隨著手術擴大轉移到門診手術中心，快速康復、簡化工作流程、術後噁心嘔吐的管理以及出院準備的重要性也日益凸顯。供應鏈韌性也是一個關鍵決定因素，醫療保健系統優先考慮品質保證的採購、庫存可視性和基本麻醉劑的緊急時應對計畫。有關標籤、藥物安全監測、職場暴露限值、回收系統和安全操作的監管要求，不斷凸顯藥房、麻醉科、生物醫學工程和永續發展團隊之間進行整合管治的必要性。

人工智慧對吸入麻醉劑的累積影響

人工智慧 (AI) 正在開始影響吸入麻醉劑領域，其作用並非取代臨床醫生的判斷，而是透過支援圍手術全期決策、預測分析以及自動化最佳化工作流程來實現。 AI 驅動的麻醉資訊管理系統可以整合並分析患者風險因素、手術類型、血流動力學趨勢、吐氣末麻醉劑濃度和通氣參數，從而支援更一致的術中管理。機器學習模型正被探索用於預測低血壓、延遲甦醒、術後噁心嘔吐和呼吸系統併發症，有助於確定麻醉劑的選擇和給藥策略。在配備先進監測系統的手術室中，AI 可以即時發出警報，提示新鮮氣體流量過大、吐氣末濃度不當或偏離低流量麻醉方案，從而保障臨床安全並減少麻醉劑浪費。此外，AI 驅動的庫存分析可以透過將使用模式與手術安排和既往病例組成進行匹配，改善揮發性麻醉劑及相關耗材的需求計劃。然而，人工智慧的實施需要檢驗的演算法、可互通的資料基礎設施、網路安全措施、透明的臨床管治，以及對醫療設備和健康資料相關法規的遵守。因此，人工智慧的累積影響最好被視為在整個吸入麻醉劑系統中加速精準麻醉、提高營運效率和永續性表現。

吸入麻醉劑的關鍵區域見解

亞太地區的特點是手術能力不斷提升、醫院基礎設施投資增加，以及大規模公立和私立醫療網路擴大採用現代麻醉設備。中國、印度、日本、韓國、澳洲和東南亞國家是該地區麻醉藥需求的核心，其需求促進因素包括手術積壓、人口老化以及專科醫療服務可近性的提高。歐洲是高度重視永續性的地區之一，醫療系統在維持嚴格法律規範的同時，也日益從環境、職業安全和臨床價值的角度評估揮發性麻醉劑。北美吸入麻醉劑的使用已趨於成熟，這得益於高手術量、廣泛的麻醉資訊系統、嚴格的藥物安全監測標準，以及越來越多的醫療機構致力於透過低流量方案和藥物選擇政策來減少麻醉氣體排放。拉丁美洲的特點是巴西、墨西哥和其他主要經濟體的手術服務可及性不斷提高，但採購的一致性、公共部門預算限制和設備現代化仍然是關鍵的考慮因素。在非洲，儘管三級醫院和都市區私立醫療機構正在擴大現代麻醉技術的普及範圍，但許多醫療系統仍將保障穩定的麻醉藥品供應、確保訓練有素的麻醉師、維護藥品供應系統以及建設安全的術後恢復基礎設施作為首要任務。在中東，尤其是在醫療基礎設施投資活躍的海灣國家，大規模的醫院建設、醫療旅遊項目以及先進手術室技術的引進正在推動醫療衛生事業的發展。

北約、七國集團、金磚國家、歐盟、東協和海灣合作理事會的關鍵集團分析

許多北約成員國擁有成熟的醫療衛生體系，優先考慮戰備、標準化的臨床方案、安全的醫療供應鏈和可互通的醫院基礎設施。所有這些都凸顯了確保可靠的吸入麻醉劑供應的重要性，無論對於民用或緊急準備而言皆是如此。七國集團（G7）國家通常擁有先進的圍手術全期基礎設施、健全的數據收集系統和完善的藥物安全監測系統，這使得麻醉實踐與脫碳努力相協調的壓力日益增大。金磚國家（BRICS）的需求各不相同，從大規模的手術能力和對國內醫療設備製造的渴望，到都市區醫療資源獲取方面的差距，都使得構建具有韌性的供應鍊和提供經濟高效的麻醉服務成為關鍵優先事項。歐盟（EU）是監管和永續性的重要標桿，其環境政策、職業安全法規和藥品品質標準影響麻醉氣體的採購、使用和廢棄物減量實踐。在東協，隨著成員國擴大外科醫療衛生基礎設施、加強全民健康納保（UHC）計劃並改善圍手術全期護理的可及性，這一點變得日益重要。吸入麻醉劑的使用取決於其價格、設備可用性和醫護人員的訓練等級。海灣合作理事會（GCC）的特點是大力投資建造先進醫院，透過認證體系品管體系，並迅速採用最先進的麻醉工作站，從而滿足了對臨床可靠吸入麻醉劑的需求，並確保了穩健的供應鏈。

主要國家吸入麻醉劑的使用趨勢

在中國，麻醉系統正透過醫院現代化、手術量增加以及先進圍手術全期技術的推廣而加強。同時，美國擁有高度發達的吸入麻醉劑環境，這得益於龐大的手術量、廣泛的門診手術、完善的麻醉監測標準以及醫療機構不斷加大力度減少排放氣體。日本的麻醉環境成熟，這得益於人口老化、高水準的手術標準和完善的醫院基礎設施。而印度的需求則受到外科手術服務擴張、私人醫療保健發展以及在各種醫療環境中對經濟高效服務模式的持續需求的影響。在德國、法國、義大利和西班牙，除了先進的手術基礎設施外，也越來越重視嚴格的歐洲監管要求、全面的臨床培訓以及臨床療效與環境責任之間的平衡。英國是環保麻醉的典範，透過專業指南和醫院舉措，推廣低排放實踐、減少不必要的氧化亞氮使用以及最佳化新鮮氣體流量。澳洲強調圍手術全期護理的品質保證、醫療專業人員標準和永續性，而韓國則結合了先進醫療技術的應用、高醫院容量和強大的外科技術，以支持現代吸入麻醉技術在三級醫療機構和專科設施中的持續實施。在加拿大，病人安全、公共醫療系統的正常運作和永續性的麻醉實踐備受重視，並日益關注低流量輸注和環保麻醉劑的使用。俄羅斯吸入麻醉劑的使用受到醫院網路規模、手術需求以及確保不同地區可靠醫療服務可近性的影響。巴西和墨西哥是拉丁美洲吸入麻醉劑領域的重要國家，這得益於手術機會的增加、對私人醫院的投資以及公共醫療設施的持續現代化。

為行業領導者提供的實用建議

產業領導者應將臨床價值、永續性和供應可靠性作為吸入麻醉劑策略的核心支柱。醫療機構可透過標準化低流量麻醉方案、審核新鮮氣體流量、投資連續氣體監測以及對麻醉團隊進行特定藥物環境特徵培訓來減少廢棄物和排放。採購負責人在評估供應商時，不僅應考慮單價，還應考慮品質保證、法規遵循、包裝完整性、供應連續性以及對藥物安全監測的支援。製造商和經銷商應加強區域庫存規劃，在適用情況下遵守儲存控制標準，建立序列化和可追溯性系統，並制定應對影響基本麻醉劑供應中斷的緊急時應對計畫。技術相關人員應開發可互通的麻醉工作站、決策支援工具和分析平台，以支援劑量準確性、職業安全和永續性的報告。臨床管治團隊應使藥物選擇決策與實證患者預後、恢復要求、禁忌症、手術室效率和環境影響保持一致。對所有相關人員（包括麻醉師、麻醉護理專家、藥劑師、生物醫學工程師和永續發展負責人）進行透明的教育，對於建立更安全、更廢棄物的吸入麻醉實踐，同時又不損害患者照護至關重要。

調查方法

本執行摘要採用結構化的實證研究方法編寫，重點關注公共衛生、監管、臨床實踐和手術全期護理方面經過檢驗的資訊來源。該調查方法包括對麻醉指南、藥物安全資訊、藥理學參考文獻、環境健康文獻、醫院永續發展舉措以及與揮發性麻醉劑和氧化亞氮相關的法規結構的審查。此外，還整合了來自已記錄的醫療基礎設施趨勢、手術准入指標、麻醉醫師考量以及影響手術室實踐的政策趨勢的區域和國家層面的見解。定性檢驗強調臨床證據、監管預期和醫療保健系統優先事項之間的一致性，同時避免對市場估算、預測、市場規模、市場佔有率或展望做出未經證實的聲明。該分析也檢視了麻醉資訊管理、氣體監測、低流量輸注系統和人工智慧驅動的圍手術全期決策支援等方面的技術應用模式。研究結果旨在為參與吸入麻醉麻醉劑系統的醫療服務提供者、供應商、政策制定者和技術開發商提供策略決策支援。

結論

吸入麻醉劑在安全有效的外科手術中仍然發揮著至關重要的作用，但其應用策略格局正在迅速變化。這一領域正朝著精準給藥、環保麻醉劑選擇、數位化監測、人工智慧驅動的決策以及強化供應鏈管治的方向發展。在醫療成熟地區，脫碳、藥物安全監測和工作流程最佳化是關鍵優先事項；而在新興醫療體系中，重點在於擴大服務覆蓋範圍、加強基礎設施建設以及確保基本麻醉劑的可靠供應。在任何地區和醫療機構中，能夠將臨床結果與永續性、合規性、營運韌性和數據驅動的麻醉管理相結合的相關人員，最有可能取得最大成功。隨著手術全期護理的不斷發展，吸入麻醉劑的重要性將持續存在，但其未來發展將取決於其給藥方式的安全性、高效性和責任性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 吸入麻醉劑市場：依產品類型分類

  • 氣體麻醉劑
  • 揮發性麻醉劑
    • DESFLURANE
    • 安氟醚
    • 哈羅坦
    • Isoflurane
    • SEVOFLURANE

第8章：吸入麻醉劑市場：依年齡層別分類

  • 成人
  • 老年人
  • 兒童

第9章：吸入麻醉劑市場：依給藥途徑及方法分類

  • 透過口罩進行管理
    • 自主呼吸
    • 輔助通風
  • 聲門上氣道給藥
  • 氣管內給藥
  • 透過人工呼吸器迴路給藥

第10章 吸入麻醉劑市場：依應用領域分類

  • 麻醉誘導
  • 麻醉維持

第11章 吸入麻醉劑市場：依最終使用者分類

  • 門診手術中心（ASC）
  • 醫院
  • ICU
  • 軍醫院/野戰醫院
  • 專科診所
  • 動物診所

第12章 吸入麻醉劑市場：依通路分類

  • 醫院直接採購
  • 批發商和分銷商
  • 向診所藥局供貨

第13章 吸入麻醉劑市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第14章 吸入麻醉劑市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第15章 吸入麻醉劑市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Baxter International Inc.
  • AbbVie Inc.
  • Pfizer Inc.
  • Hikma Pharmaceuticals PLC
  • Fresenius Kabi AG
  • Piramal Enterprises Limited
  • Troikaa Pharmaceuticals Ltd.
  • Halocarbon
  • Dechra Veterinary Products Limited
  • Maruishi Pharmaceutical Co., Ltd.
  • Abbott Laboratories
  • Aetos Pharma Private Limited
  • Dotcom Pharma
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  • Lunan Pharmaceutical Group Co. Ltd.
  • Novartis AG
  • Raman & Weil Private Limited
  • Supriya Lifescience Ltd
Product Code: MRR-742BD517FC4B

The Inhalation Anesthetics Market is projected to grow by USD 2.00 billion at a CAGR of 6.85% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.25 billion
Estimated Year [2026] USD 1.34 billion
Forecast Year [2032] USD 2.00 billion
CAGR (%) 6.85%

Inhalation anesthetics remain a cornerstone of modern anesthesia practice because they enable controllable induction, maintenance, and emergence across a wide range of surgical and procedural settings. Agents such as sevoflurane, desflurane, isoflurane, and nitrous oxide are used in operating rooms, ambulatory surgery centers, obstetric units, and selected critical care environments where rapid titration and predictable recovery are clinically important. Demand is shaped by rising surgical volumes, aging populations with higher procedural needs, expansion of outpatient surgery, and continued investment in perioperative safety. At the same time, the inhalation anesthetics landscape is increasingly influenced by environmental scrutiny, occupational exposure controls, low-flow anesthesia techniques, and the adoption of advanced anesthesia workstations that support precision delivery and gas monitoring. For healthcare providers, procurement teams, and policy stakeholders, the sector is defined not only by clinical efficacy but also by sustainability, supply reliability, regulatory compliance, and total cost of care.

Transformative Shifts in the Inhalation Anesthetics Landscape

The inhalation anesthetics landscape is undergoing a structural shift from routine product utilization toward value-driven, safety-focused, and environmentally responsible anesthesia delivery. Hospitals are adopting low-flow and minimal-flow anesthesia protocols to reduce anesthetic gas consumption while maintaining adequate depth of anesthesia and patient safety. This shift is supported by modern vaporizers, integrated gas analyzers, closed-loop monitoring concepts, and clinical training focused on fresh gas flow optimization. Environmental considerations are also reshaping formulary decisions, as volatile anesthetics vary in atmospheric persistence and global warming potential, with desflurane and nitrous oxide receiving heightened scrutiny in many health systems. In parallel, the migration of procedures to ambulatory surgery centers is increasing the emphasis on rapid recovery profiles, workflow efficiency, postoperative nausea and vomiting management, and discharge readiness. Supply chain resilience has become another defining factor, with healthcare systems prioritizing quality-assured sourcing, inventory visibility, and contingency planning for essential anesthetic agents. Regulatory expectations around labeling, pharmacovigilance, workplace exposure limits, scavenging systems, and safe handling continue to reinforce the need for integrated governance across pharmacy, anesthesia, biomedical engineering, and sustainability teams.

Cumulative Impact of Artificial Intelligence on Inhalation Anesthetics

Artificial intelligence is beginning to influence inhalation anesthetics through perioperative decision support, predictive analytics, and automation-enabled workflow improvements rather than replacing clinician judgment. AI-supported anesthesia information management systems can help synthesize patient risk factors, procedure type, hemodynamic trends, end-tidal anesthetic concentration, and ventilation parameters to support more consistent intraoperative management. Machine learning models are being explored for predicting hypotension, delayed emergence, postoperative nausea and vomiting, and respiratory complications, which can inform anesthetic selection and dosing strategies. In operating rooms equipped with advanced monitoring, AI can contribute to real-time alerts for excessive fresh gas flow, suboptimal end-tidal concentrations, or deviations from low-flow anesthesia protocols, supporting both clinical safety and reduced anesthetic waste. AI-enabled inventory analytics can also improve demand planning for volatile anesthetic agents and related consumables by aligning usage patterns with surgical schedules and historical case mix. However, adoption depends on validated algorithms, interoperable data infrastructure, cybersecurity controls, transparent clinical governance, and compliance with medical device and health data regulations. The cumulative impact of AI is therefore best understood as an acceleration of precision anesthesia, operational efficiency, and sustainability performance across the inhalation anesthetics ecosystem.

Key Regional Insights for Inhalation Anesthetics

Asia-Pacific is characterized by expanding surgical capacity, rising hospital infrastructure investment, and growing adoption of modern anesthesia equipment across large public and private healthcare networks. China, India, Japan, South Korea, Australia, and Southeast Asian countries are central to regional activity, with demand influenced by elective surgery backlogs, aging demographics, and increased access to specialist care. Europe is one of the most sustainability-focused regions, with health systems increasingly evaluating volatile anesthetics through environmental, occupational safety, and clinical value lenses while maintaining rigorous regulatory oversight. North America demonstrates mature use of inhalation anesthetics, supported by high procedural intensity, widespread anesthesia information systems, strong pharmacovigilance standards, and growing institutional focus on reducing anesthetic gas emissions through low-flow protocols and agent selection policies. Latin America is shaped by expanding access to surgical care in Brazil, Mexico, and other major economies, though procurement consistency, public-sector budget constraints, and equipment modernization remain important considerations. Africa presents a diverse picture in which tertiary hospitals and urban private facilities are expanding access to modern anesthesia, while many systems continue to prioritize reliable supply, trained anesthesia workforce capacity, maintenance of delivery systems, and safe scavenging infrastructure. The Middle East is advancing through major hospital development, medical tourism initiatives, and adoption of advanced operating room technologies, particularly in Gulf countries with high healthcare infrastructure investment.

Key Group Insights Across NATO, G7, BRICS, EU, ASEAN, and GCC

NATO countries include many mature healthcare systems with emphasis on readiness, standardized clinical protocols, secure medical supply chains, and interoperable hospital infrastructure, all of which reinforce the importance of reliable inhalation anesthetic availability in both civilian and emergency preparedness contexts. G7 countries generally demonstrate advanced perioperative infrastructure, strong data capture, established pharmacovigilance systems, and increasing pressure to align anesthesia practice with decarbonization commitments. BRICS countries collectively reflect a broad spectrum of needs, from high-volume surgical systems and domestic healthcare manufacturing ambitions to uneven access across urban and rural settings, making resilient supply and cost-effective anesthesia delivery key priorities. The European Union is a major regulatory and sustainability reference point, with environmental policy, occupational safety rules, and pharmaceutical quality standards influencing anesthetic gas procurement, use, and waste reduction practices. ASEAN is gaining importance as member states expand surgical infrastructure, strengthen universal health coverage programs, and improve access to perioperative care, with inhalation anesthetic use shaped by affordability, equipment availability, and workforce training. The GCC is distinguished by high investment in advanced hospitals, accreditation-driven quality systems, and rapid adoption of modern anesthesia workstations, supporting demand for clinically reliable inhaled agents and strong supply chain assurance.

Key Country Insights for Inhalation Anesthetics

China is strengthening anesthesia capacity through hospital modernization, rising procedure volumes, and broader adoption of advanced perioperative technologies, while the United States remains a highly developed inhalation anesthetics environment supported by large surgical volumes, extensive ambulatory surgery utilization, robust anesthesia monitoring standards, and growing institutional initiatives to reduce operating room emissions. Japan has a mature anesthesia environment supported by an aging population, high procedural standards, and sophisticated hospital infrastructure, whereas India's demand is shaped by expanding surgical care, growth in private healthcare, and a continuing need for cost-effective delivery models across varied care settings. Germany, France, Italy, and Spain combine advanced surgical infrastructure with strict European regulatory expectations, strong clinical training, and increasing focus on balancing clinical outcomes with environmental responsibility. The United Kingdom has become a prominent reference for environmentally conscious anesthesia, with professional guidance and hospital initiatives encouraging lower-emission practices, reduced unnecessary nitrous oxide use, and fresh gas flow optimization. Australia emphasizes quality assurance, workforce standards, and sustainability in perioperative care, and South Korea combines advanced medical technology adoption, high hospital capability, and strong surgical specialization, supporting continued use of modern inhalation anesthetic practices across tertiary and specialist facilities. Canada emphasizes patient safety, public health system stewardship, and sustainability-oriented anesthesia practice, with increasing attention to low-flow delivery and environmentally preferable agent use. Russia's inhalation anesthetics use is influenced by the scale of its hospital network, surgical demand, and the need for dependable access across diverse geographies. Brazil and Mexico are important Latin American countries for inhalation anesthetics due to expanding surgical access, investment in private hospitals, and continuing modernization of public healthcare facilities.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical value, sustainability, and supply reliability as the central pillars of inhalation anesthetics strategy. Healthcare organizations can reduce waste and emissions by standardizing low-flow anesthesia protocols, auditing fresh gas flow behavior, investing in continuous gas monitoring, and training anesthesia teams on agent-specific environmental profiles. Procurement leaders should evaluate suppliers through quality assurance, regulatory compliance, packaging integrity, continuity of supply, and support for pharmacovigilance rather than focusing solely on unit price. Manufacturers and distributors should strengthen regional inventory planning, controlled storage compliance where applicable, serialization and traceability systems, and contingency planning for disruptions affecting essential anesthetic agents. Technology stakeholders should develop interoperable anesthesia workstations, decision-support tools, and analytics platforms that support dosing precision, occupational safety, and sustainability reporting. Clinical governance teams should align formulary decisions with evidence-based patient outcomes, recovery requirements, contraindications, operating room efficiency, and environmental impact. Across all stakeholders, transparent education for anesthesiologists, nurse anesthetists, pharmacists, biomedical engineers, and sustainability officers will be essential to embedding safer, lower-waste inhalation anesthetic practices without compromising patient care.

Research Methodology

This executive summary is developed using a structured, evidence-oriented research approach focused on verified public health, regulatory, clinical, and perioperative practice sources. The methodology includes review of anesthesia guidelines, medicine safety communications, pharmacology references, environmental health literature, hospital sustainability initiatives, and regulatory frameworks relevant to volatile anesthetic agents and nitrous oxide. Regional and country-level insights are synthesized from documented healthcare infrastructure trends, surgical access indicators, anesthesia workforce considerations, and policy developments affecting operating room practice. Qualitative validation emphasizes consistency across clinical evidence, regulatory expectations, and health system priorities, while avoiding unsupported claims related to market estimation, market sizing, market share, or forecasting. The analysis also considers technology adoption patterns in anesthesia information management, gas monitoring, low-flow delivery systems, and AI-enabled perioperative decision support. Findings are presented to support strategic decision-making for healthcare providers, suppliers, policymakers, and technology developers involved in the inhalation anesthetics ecosystem.

Conclusion

Inhalation anesthetics continue to play an essential role in safe and effective surgical care, but the strategic context surrounding their use is changing rapidly. The sector is moving toward precision delivery, environmentally responsible agent selection, digital monitoring, AI-supported decision-making, and stronger supply chain governance. Mature regions are emphasizing decarbonization, pharmacovigilance, and workflow optimization, while emerging healthcare systems are focused on expanding access, strengthening infrastructure, and ensuring dependable availability of essential anesthetic agents. Across regions and care settings, the most successful stakeholders will be those that integrate clinical performance with sustainability, compliance, operational resilience, and data-driven anesthesia management. As perioperative care evolves, inhalation anesthetics will remain important, but their future will be defined by how safely, efficiently, and responsibly they are delivered.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Inhalation Anesthetics Market, by Product Type

  • 7.1. Introduction
  • 7.2. Gaseous Anesthetics
  • 7.3. Volatile Anesthetics
    • 7.3.1. Desflurane
    • 7.3.2. Enflurane
    • 7.3.3. Halothane
    • 7.3.4. Isoflurane
    • 7.3.5. Sevoflurane

8. Inhalation Anesthetics Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adult
  • 8.3. Geriatric
  • 8.4. Pediatric

9. Inhalation Anesthetics Market, by Route & Delivery

  • 9.1. Introduction
  • 9.2. Face Mask Delivery
    • 9.2.1. Spontaneous Ventilation
    • 9.2.2. Assisted Ventilation
  • 9.3. Supraglottic Airway Delivery
  • 9.4. Endotracheal Delivery
  • 9.5. Ventilator Circuit Delivery

10. Inhalation Anesthetics Market, by Application

  • 10.1. Introduction
  • 10.2. Induction of Anesthesia
  • 10.3. Maintenance of Anesthesia

11. Inhalation Anesthetics Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers (ASCs)
  • 11.3. Hospitals
  • 11.4. ICUs
  • 11.5. Military/Field Hospitals
  • 11.6. Specialty Clinics
  • 11.7. Veterinary Clinics

12. Inhalation Anesthetics Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Direct Hospital Procurement
  • 12.3. Wholesalers & Distributors
  • 12.4. Clinic Pharmacy Supply

13. Inhalation Anesthetics Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. Europe
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Africa
  • 13.6. Middle East

14. Inhalation Anesthetics Market, by Group

  • 14.1. NATO
  • 14.2. G7
  • 14.3. BRICS
  • 14.4. European Union
  • 14.5. ASEAN
  • 14.6. GCC

15. Inhalation Anesthetics Market, by Country

  • 15.1. China
  • 15.2. United States
  • 15.3. Japan
  • 15.4. India
  • 15.5. Germany
  • 15.6. United Kingdom
  • 15.7. Australia
  • 15.8. France
  • 15.9. South Korea
  • 15.10. Italy
  • 15.11. Canada
  • 15.12. Russia
  • 15.13. Brazil
  • 15.14. Mexico
  • 15.15. Spain

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Baxter International Inc.
  • 17.2. AbbVie Inc.
  • 17.3. Pfizer Inc.
  • 17.4. Hikma Pharmaceuticals PLC
  • 17.5. Fresenius Kabi AG
  • 17.6. Piramal Enterprises Limited
  • 17.7. Troikaa Pharmaceuticals Ltd.
  • 17.8. Halocarbon
  • 17.9. Dechra Veterinary Products Limited
  • 17.10. Maruishi Pharmaceutical Co., Ltd.
  • 17.11. Abbott Laboratories
  • 17.12. Aetos Pharma Private Limited
  • 17.13. Dotcom Pharma
  • 17.14. Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  • 17.15. Lunan Pharmaceutical Group Co. Ltd.
  • 17.16. Novartis AG
  • 17.17. Raman & Weil Private Limited
  • 17.18. Supriya Lifescience Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL INHALATION ANESTHETICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL INHALATION ANESTHETICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL INHALATION ANESTHETICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL INHALATION ANESTHETICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL INHALATION ANESTHETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASEOUS ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASEOUS ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASEOUS ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VOLATILE ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VOLATILE ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VOLATILE ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DESFLURANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DESFLURANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DESFLURANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENFLURANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HALOTHANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HALOTHANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HALOTHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ISOFLURANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ISOFLURANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ISOFLURANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SEVOFLURANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SEVOFLURANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SEVOFLURANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FACE MASK DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FACE MASK DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FACE MASK DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SPONTANEOUS VENTILATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SPONTANEOUS VENTILATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SPONTANEOUS VENTILATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ASSISTED VENTILATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ASSISTED VENTILATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ASSISTED VENTILATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SUPRAGLOTTIC AIRWAY DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SUPRAGLOTTIC AIRWAY DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SUPRAGLOTTIC AIRWAY DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOTRACHEAL DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOTRACHEAL DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOTRACHEAL DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VENTILATOR CIRCUIT DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VENTILATOR CIRCUIT DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VENTILATOR CIRCUIT DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INDUCTION OF ANESTHESIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INDUCTION OF ANESTHESIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INDUCTION OF ANESTHESIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MAINTENANCE OF ANESTHESIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAINTENANCE OF ANESTHESIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MAINTENANCE OF ANESTHESIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ICUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ICUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ICUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MILITARY/FIELD HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MILITARY/FIELD HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MILITARY/FIELD HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIRECT HOSPITAL PROCUREMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DIRECT HOSPITAL PROCUREMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIRECT HOSPITAL PROCUREMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL WHOLESALERS & DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL WHOLESALERS & DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL WHOLESALERS & DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CLINIC PHARMACY SUPPLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CLINIC PHARMACY SUPPLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CLINIC PHARMACY SUPPLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. NATO INHALATION ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. NATO INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. NATO INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 149. NATO INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. NATO INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 151. NATO INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 152. NATO INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. NATO INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. NATO INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. G7 INHALATION ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. G7 INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. G7 INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 158. G7 INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. G7 INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 160. G7 INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. G7 INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. G7 INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS INHALATION ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. GCC INHALATION ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. GCC INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. GCC INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 196. GCC INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. GCC INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. JAPAN INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 220. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 222. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 223. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 224. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 225. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. INDIA INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. INDIA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. INDIA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 231. INDIA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 232. INDIA INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 233. INDIA INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 234. INDIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. INDIA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. INDIA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. GERMANY INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 240. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 242. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 243. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 258. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 259. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 260. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 261. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. FRANCE INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 267. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 268. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 269. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 270. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 276. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 277. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 278. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 279. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. ITALY INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. ITALY INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. ITALY INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 285. ITALY INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 286. ITALY INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 287. ITALY INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 288. ITALY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. ITALY INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. ITALY INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 291. CANADA INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 292. CANADA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. CANADA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 294. CANADA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 295. CANADA INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 296. CANADA INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 297. CANADA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 298. CANADA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. CANADA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. RUSSIA INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 301. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 303. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 304. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 305. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 306. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 309. BRAZIL INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 312. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 313. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 314. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 315. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 318. MEXICO INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 319. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 321. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 322. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 323. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 324. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 325. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 326. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 327. SPAIN INHALATION ANESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 328. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 329. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 330. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 331. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY ROUTE & DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 332. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY FACE MASK DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 333. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 334. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 335. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 336. GLOBAL INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 337. GLOBAL INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025